{"transactions":[{"id":1175373,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T20:41:36.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2025-12-01","underlying":"Voting Common Shares","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001760016-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176001625000004/primary_doc.xml","form_type":"4"}},{"id":1175372,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-04-08T20:41:36.000Z","date":"2025-04-07","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":2.11,"value":50640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time."}],"balance_after":312995,"source":{"system":"sec-edgar","filing":"0001760016-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000176001625000004/primary_doc.xml","form_type":"4"}},{"id":1314217,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:23:03.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10393,"price":5.34,"value":55498.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $55,500.  The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time."}],"balance_after":288995,"source":{"system":"sec-edgar","filing":"0001235802-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000002/primary_doc.xml","form_type":"4"}},{"id":1494975,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:29:48.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":36065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":36065,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":36065},"source":{"system":"sec-edgar","filing":"0001235802-24-000048","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000048/primary_doc.xml","form_type":"4"}},{"id":1696366,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T21:47:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":30357,"price":2.8,"value":84999.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 129,561 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":278602,"source":{"system":"sec-edgar","filing":"0001235802-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000003/primary_doc.xml","form_type":"4"}},{"id":1844116,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:03:48.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":38363,"price":3.91,"value":149999.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 99,204 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":248245,"source":{"system":"sec-edgar","filing":"0001235802-23-000068","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000068/primary_doc.xml","form_type":"4"}},{"id":1869421,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:26:40.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":22355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":22355,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":22355},"source":{"system":"sec-edgar","filing":"0001235802-23-000059","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000059/primary_doc.xml","form_type":"4"}},{"id":2072456,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:19:56.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":55555,"price":1.53,"value":84999.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 99,204 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":209882,"source":{"system":"sec-edgar","filing":"0001235802-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000001/primary_doc.xml","form_type":"4"}},{"id":2095902,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-05T21:16:42.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":35000,"price":1.3855,"value":48492.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.3665 to $1.4047, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 43,649 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":154327,"source":{"system":"sec-edgar","filing":"0001235802-22-000130","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000130/primary_doc.xml","form_type":"4"}},{"id":2247262,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T20:38:52.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":18510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":18510,"derivative":{"exercise_price":2.45,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":18510},"source":{"system":"sec-edgar","filing":"0001235802-22-000071","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000071/primary_doc.xml","form_type":"4"}},{"id":2454051,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-01-03T21:26:48.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":23762,"price":3.58,"value":85067.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 43,649 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":119327,"source":{"system":"sec-edgar","filing":"0001235802-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000003/primary_doc.xml","form_type":"4"}},{"id":2599817,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-08-17T20:05:23.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":12500,"price":3.2826,"value":41032.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":95565,"source":{"system":"sec-edgar","filing":"0001235802-21-000100","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000100/primary_doc.xml","form_type":"4"}},{"id":2599816,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-08-17T20:05:23.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":2500,"price":3.2126,"value":8031.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":83065,"source":{"system":"sec-edgar","filing":"0001235802-21-000100","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000100/primary_doc.xml","form_type":"4"}},{"id":2631888,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-16T20:40:23.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":13150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":13150,"derivative":{"exercise_price":3.64,"expiration_date":"2031-07-14","underlying":"Common Shares","underlying_shares":13150},"source":{"system":"sec-edgar","filing":"0001235802-21-000080","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000080/primary_doc.xml","form_type":"4"}},{"id":2925377,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-01-04T21:12:28.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":9719,"price":8.23,"value":79987.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $80,000."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":80565,"source":{"system":"sec-edgar","filing":"0001235802-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000001/primary_doc.xml","form_type":"4"}},{"id":2956460,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-12-04T22:46:36.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":5000,"price":5.24,"value":26200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 10,168 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":70846,"source":{"system":"sec-edgar","filing":"0001790300-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000179030020000011/primary_doc.xml","form_type":"4"}},{"id":2956459,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-12-04T22:46:36.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":5000,"price":5.4994,"value":27497.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 10,168 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan."}],"balance_after":65846,"source":{"system":"sec-edgar","filing":"0001790300-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000179030020000011/primary_doc.xml","form_type":"4"}},{"id":3126742,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T20:33:22.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":19220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":19220,"derivative":{"exercise_price":4.64,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":19220},"source":{"system":"sec-edgar","filing":"0001235802-20-000049","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000049/primary_doc.xml","form_type":"4"}},{"id":3126741,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-06-02T20:33:22.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":10168,"price":4.59,"value":46671.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $46,667."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":60846,"source":{"system":"sec-edgar","filing":"0001235802-20-000049","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000049/primary_doc.xml","form_type":"4"}},{"id":3434351,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2019-08-19T10:45:40.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":7840,"price":2.556,"value":20039.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.5387 to $2.5775, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":50678,"source":{"system":"sec-edgar","filing":"0001235802-19-000107","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000107/primary_doc.xml","form_type":"4"}},{"id":3477984,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-26T20:48:41.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in four equal quarterly installments over one year."}],"balance_after":18700,"derivative":{"exercise_price":4.6,"expiration_date":"2029-06-23","underlying":"Common Shares","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0001235802-19-000065","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000065/primary_doc.xml","form_type":"4"}},{"id":3506176,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2019-05-31T20:11:28.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":19000,"price":2.8,"value":53200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.74 to $2.80, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":42838,"source":{"system":"sec-edgar","filing":"0001235802-19-000045","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000045/primary_doc.xml","form_type":"4"}},{"id":3735341,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":80958,"kind":"person","name":"Pilnik Richard D.","position":1,"cik":"0001760016","reported_name":"Pilnik Richard D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2018-12-11T21:37:31.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":6250,"price":4,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan."}],"balance_after":23838,"source":{"system":"sec-edgar","filing":"0001235802-18-000183","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580218000183/primary_doc.xml","form_type":"4"}}]}